Matthew L Broadhead1, Crispin R Dass, Peter F M Choong. 1. University of Melbourne, St. Vincent's Hospital, Department of Orthopaedics and Surgery, L3, Daly Wing, 35 Victoria Pde., Fitzroy 3065, VIC, Australia.
Abstract
BACKGROUND: Pigment epithelium-derived factor (PEDF) is an emerging anti-cancer agent that targets both tumor tissue and its supporting vasculature. These direct and indirect effects of PEDF have been examined in vitro and in vivo for a range of malignancies. OBJECTIVE: This review seeks to present PEDF as a potential anti-cancer agent with applications across multiple malignancies. We refer closely to experimental methodology whilst still highlighting the clinical significance of PEDF in cancer, drawing on biological findings in vitro and in vivo. METHODS: A Pubmed database search was performed limiting the scope of this discussion paper mainly to PEDF's biological role in cancer, specifically lung, breast, prostatic, ovarian and pancreatic carcinomas, melanoma, glioma and osteosarcoma. CONCLUSIONS: The biological roles of PEDF are diverse and multidimensional. As an anti-cancer agent, PEDF has great potential as a focused anti-neoplastic therapy against a variety of tumor types.
BACKGROUND:Pigment epithelium-derived factor (PEDF) is an emerging anti-cancer agent that targets both tumor tissue and its supporting vasculature. These direct and indirect effects of PEDF have been examined in vitro and in vivo for a range of malignancies. OBJECTIVE: This review seeks to present PEDF as a potential anti-cancer agent with applications across multiple malignancies. We refer closely to experimental methodology whilst still highlighting the clinical significance of PEDF in cancer, drawing on biological findings in vitro and in vivo. METHODS: A Pubmed database search was performed limiting the scope of this discussion paper mainly to PEDF's biological role in cancer, specifically lung, breast, prostatic, ovarian and pancreatic carcinomas, melanoma, glioma and osteosarcoma. CONCLUSIONS: The biological roles of PEDF are diverse and multidimensional. As an anti-cancer agent, PEDF has great potential as a focused anti-neoplastic therapy against a variety of tumor types.
Authors: Maria Demestre; Menderes Yusuf Terzi; Victor Mautner; Peter Vajkoczy; Andreas Kurtz; Ana Luisa Piña Journal: J Neurooncol Date: 2013-12 Impact factor: 4.130
Authors: Mateusz S Wietecha; Mateusz J Król; Elizabeth R Michalczyk; Lin Chen; Peter G Gettins; Luisa A DiPietro Journal: Am J Physiol Heart Circ Physiol Date: 2015-07-10 Impact factor: 4.733
Authors: Jacob E Koskimaki; Elena V Rosca; Corban G Rivera; Esak Lee; William Chen; Niranjan B Pandey; Aleksander S Popel Journal: Transl Oncol Date: 2012-04-01 Impact factor: 4.243